Ontology highlight
ABSTRACT: Background
Advances in postnatal care for hemolytic disease of the fetus and newborn (HDFN) have occurred over the past decades, but little is known regarding the frequency of postnatal treatment and the clinical outcomes of affected neonates. Most studies reporting on HDFN originate from high-income countries or relatively large centers, but important differences between centers and countries may exist due to differences in prevalence and available treatment options. We therefore aimed to evaluate the postnatal treatment landscape and clinical outcomes in neonates with Rhesus factor D (Rh(D))- and/or K-mediated HDFN and to provide recommendations for future research.Methods
We conducted a rapid literature review of case reports and series, observational retrospective and p
SUBMITTER: de Winter DP
PROVIDER: S-EPMC10583489 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature